Epigenetic drug discovery and tools
 

Management and Board

Management

 

    Barrie Ward   Executive Chairman
    Will West   Chief Executive
    Tim Fell  Chief Operating Officer
    David Knowles  Chief Scientific Officer
    Nessa Carey  Scientific Director
    Neil Pegg Director of Discovery Research
    Jonathan Best Programme Manager
    Dev Crease  Patent Counsel
    Richard Brooks Finance Director
    Thea Stanway  Finance Officer

  

Board

 

    Barrie Ward  Executive Chairman
    Will West  Executive Director
    Tim Fell Executive Director
    David Knowles  Executive Director
    Gerald Chan Non-Executive Director
    Sue Foden Non-Executive Director
    Dan Roach Non-Executive Director
    David Secher Non-Executive Director
    Azim Surani Board Observer
 

  

Jonathan Best (Programme Manager)

Jonathan BestJonathan obtained his degree in Zoology at UCL and his PhD. in the Dept. of Anatomy at the University of Cambridge. After conducting his post-doctoral research at Dartmouth Medical School, New Hampshire USA, he joined Merck, Sharp and Dohme in 2001 as team leader investigating therapeutics for neurodegenerative diseases in particular Alzheimer’s Disease and was a member of the project team which delivered 5 NCEs for development of which one is currently in the clinic. He then joined Summit plc as leader of the cognition project, using both reprofiling and NCE approaches for discovering therapeutics for neurological diseases. He joined CellCentric in February 2008, where he is responsible for overseeing the drug discovery programmes currently being conducted by Contract Research Organisations for CellCentric.